Justin D. Hoopes

Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro

Jack Nguyen, Justin D. Hoopes, Lê Minh Hà et al. · PLoS ONE · 2010 · 175 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

TLR3 Deletion Limits Mortality and Disease Severity due to Phlebovirus Infection

Brian B. Gowen, Justin D. Hoopes, Min‐Hui Wong et al. · The Journal of Immunology · 2006 · 129 citations

Life Sciences, Immunology, Infectious Diseases +17

Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro

Jack Nguyen, Justin D. Hoopes, Donald F. Smee et al. · Antimicrobial Agents and Chemotherapy · 2009 · 115 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin

Dale L. Barnard, Craig W. Day, Kevin W. Bailey et al. · Antiviral Research · 2006 · 104 citations

Medicine, Infectious Diseases, Pharmacology +14

Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

Yajing Bao, Joy Beeler, Weerawat Manosuthi et al. · The Lancet Infectious Diseases · 2017 · 99 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +10